论文部分内容阅读
目的对近年来我院收治的结核病人耐多药现状及防治措施进行探讨。方法选取2008年1月至2014年1月期间收治的545例结核病人作为研究对象,对其临床资料进行回顾分析。结果根据初次治疗和再次治疗将患者分为两组,初治组410例,耐药率为16.1%,耐多药率为3.7%,复治组135例,耐药率为25.2%,耐多药率为17.0%,复治组明显高于初治组,差异显著,有统计学意义,P<0.05。结论结核病人耐多药情况较为严重,必须进行结核病控制,保证对耐多药结核病人进行有效、规范的管理,避免耐药菌株繁殖与传播。
Objective To investigate the status of multidrug-resistant tuberculosis (MDR) patients in our hospital and the prevention and treatment measures in recent years. Methods A total of 545 TB patients admitted from January 2008 to January 2014 were selected as the study subjects, and their clinical data were retrospectively analyzed. Results According to the initial treatment and re-treatment, the patients were divided into two groups. The initial treatment group consisted of 410 cases with resistance rate of 16.1%, resistance rate of multi-drug group of 3.7%, and retreatment group of 135 cases with resistance rate of 25.2% The rate of drug was 17.0%. The retreatment group was significantly higher than the initial treatment group, the difference was significant, with statistical significance, P <0.05. Conclusion The MDR status of tuberculosis patients is more serious. Tuberculosis control must be carried out to ensure effective and standardized management of MDR-TB patients and prevent the propagation and spread of drug-resistant strains.